Danish pharma giant Novo Nordisk has launched its once-weekly semaglutide injection, Ozempic, in India, priced at ₹8,800 for 0.25 mg, ₹10,170 for 0.5 mg, and ₹11,175 for 1 mg, translating to a weekly starting cost of around ₹2,200. Approved as an adjunct to diet and exercise, Ozempic is aimed at adults with type-2 diabetes with […]Continue Reading
